We specialize in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. With our proprietary MATCH technology platform, we are fueling a new wave of multi-specific drug candidates engineered with versatility and developability in mind.
Cooperation possibilities
Numab offers its discovery and development capabilities to industry partners who are looking for innovative antibody-based products. For further information please contact partnering@numab.com.
- http://www.numab.com
- info@numab.com
- David Urech
